Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-29 @ 12:36 PM
Study NCT ID:
NCT07027657
Status:
RECRUITING
Last Update Posted:
2025-07-21
First Post:
2025-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress
Sponsor:
BTL Industries Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-11
First Submit QC Date:
None
Study First Post Date:
2025-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-17
Last Update Post Date:
2025-07-21
Last Update Post Date Type:
ACTUAL